The trial will assess various approaches, including different PSA thresholds, standalone MRI, MRI with PSA testing and polygenic risk scores (PRS), with the aim of identifying the most effective PCa screening method.103. The gene discussed is KLK3; the disease is posterior cortical atrophy.